News
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...
Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), its partner for the Comirnaty COVID-19 vaccine, made legal submissions to ...
Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...
It argues that Pfizer and BioNtech's vaccine infringes patents Moderna filed between 2010 and 2016 for its messenger RNA or mRNA technology. All three companies' COVID-19 vaccines used mRNA ...
Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in ...
Moderna and Pfizer/BioNTech earned more than $110 billion from their COVID vaccines. Read how patent infringement cases could impact their respective businesses.
A federal court dismissed a journalist’s claims against Pfizer executives and a member of the former Biden Administration for ...
Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday gave Pfizer permission to take the case to the Court of Appeal. Pfizer and ...
Coronavirus Covid-19 omicron mutation. Freshfields has won a Düsseldorf regional court patent dispute on behalf of client Moderna against German COVID-19 vaccine inventors BioNTech and Pfizer ...
FILE - This Sept. 21, 2021 file photo shows vials of the Pfizer and Moderna COVID-19 vaccines in Jackson, Miss. Moderna is suing its main competitors Pfizer and the German drugmaker BioNTech ...
Moderna is suing Pfizer and BioNTech, accusing the companies of infringing on Moderna’s patents when they developed their own COVID-19 vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results